Clinical Trial Update: Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the addition of omarigliptin versus sitagliptin in adults with type 2 diabetes inadequately controlled on metformin; study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Omarigliptin (omarigliptin)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2015-11-25